No-Spa (Drotaverine Hydrochloride)

Drotaverine hydrochloride inhibits the enzyme phosphodiesterase‑4, which leads to increased intracellular cyclic AMP (cAMP) in smooth‑muscle cells. Higher cAMP levels decrease calcium availability, resulting in reduced muscle contractility and relaxation of smooth muscle in the gastrointestinal, uterine, biliary and vascular systems. This mechanism provides targeted antispasmodic action without significant anticholinergic effects.

The appropriate dose of No‑Spa is determined by a qualified healthcare professional based on the individual’s condition, age, weight and overall health status. Prescribers consider the severity of symptoms and any concomitant medications before selecting the dosage form and regimen. Patients should follow the exact instructions provided on the prescription label.

Safety data for drotaverine during pregnancy are limited, so it should only be used if the potential benefit outweighs any possible risk and under medical supervision. While small amounts are excreted in breast milk, caution is advised for nursing mothers, and a healthcare provider should evaluate the risk‑benefit balance before prescribing.

To request No‑Spa, visit the product page on gnhindia.com, enter the desired quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control) and assistance with import documentation.

Compared with anticholinergic agents such as hyoscine, drotaverine provides smooth‑muscle relaxation without significant anticholinergic side effects like dry mouth or blurred vision. Its phosphodiesterase‑4 inhibition offers a more selective mechanism, often resulting in better tolerability for patients who need relief from visceral cramps but wish to avoid strong anticholinergic activity.

No‑Spa tablets should be stored at room temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect them from moisture, excessive heat and direct sunlight. Do not store in the refrigerator or freezer, and keep out of reach of children.

No‑Spa is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless directed by a healthcare professional. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber.

Although rare, serious adverse reactions can include severe hypotension, allergic responses such as rash, swelling or anaphylaxis, and hepatic enzyme elevations indicating possible liver involvement. Patients experiencing any of these symptoms should seek immediate medical attention. Regular monitoring is recommended for individuals with pre‑existing cardiovascular or liver conditions.

No‑Spa is contraindicated in individuals with known hypersensitivity to drotaverine or any of the tablet’s excipients. It should also be avoided in patients with severe uncontrolled hypotension, acute cardiac failure, or those taking other potent smooth‑muscle relaxants without medical supervision. Pregnant or breastfeeding women should only use it when clearly indicated by a physician.